About the Company
edwards lifesciences (nyse: ew) is the global leader in the science of heart valves and hemodynamic monitoring. driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. headquartered in irvine, california, edwards lifesciences has extensive operations in north america, europe, japan, latin america and asia and currently employs about 6,400 individuals worldwide. for us, helping patients is not a slogan – it's our life’s work. from developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $EW News
Edwards Lifesciences Sued for $140 Million Over Device Deal
Ex-investors in Harpoon Medical Inc. sued Edwards Lifesciences Corp. affiliates, saying the cardiac equipment maker owes them $140 million more for failing to commercialize a heart valve device it ...
If You Invested $1000 in Edwards Lifesciences a Decade Ago, This is How Much It'd Be Worth Now
Edwards Lifesciences Corporation, headquartered in Irvine, CA, deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ...
Edwards Says Mussallem to Retire as Chairman
Mike Mussallem, who built Irvine-based Edwards Lifesciences Corp. into a company worth $57 billion, is retiring as executive ...
The Latest Analyst Ratings For Edwards Lifesciences
Insights from analysts' 12-month price targets are revealed, presenting an average target of $91.56, a high estimate of ...
Edwards Lifesciences’ chair Michael Mussallem retires from board
Edwards Lifesciences' Chair Michael Mussallem is retiring from the board of directors a year after stepping down as CEO.
Edwards Lifesciences
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...
Edwards Lifesciences Longtime Chair To Retire
By Ben Glickman Edwards Lifesciences said Tuesday that chair Michael Mussallem planned to retire about a year after stepping down as chief executive.
Meril Defeats Edwards Lifesciences’ Patent Lawsuit on Appeal
Indian medical device company Meril Inc. cemented its successful defense from rival artificial heart-valve maker Edwards Lifesciences Corp.'s patent infringement suit at the Federal Circuit.
Edwards Lifesciences Corp EW
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Edwards Lifesciences Corporation's (NYSE:EW) Intrinsic Value Is Potentially 17% Below Its Share Price
Edwards Lifesciences is estimated to be 21% overvalued based on current share price of US$92.85 Our fair value estimate is 16 ...
Federal Circuit Applies Safe Harbor to Imported Medical Device Samples
In Edwards Lifesciences Corp. v. Meril Life Sciences Pvt. Ltd., decided on March 25, 2024, a majority panel of the Federal Circuit held that the importation of medical devices to support efforts to ...
Edwards Lifesciences Corp EW
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...